Literature DB >> 2935404

Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells.

U D Staerz, M J Bevan.   

Abstract

The murine monoclonal antibody F23.1 reacts with an allotypic determinant on the T cell receptors of about 25% of peripheral T lymphocytes in most common mouse strains. In this report we demonstrate that this IgG2a antibody bound to the receptor of a cytotoxic effector T cell can direct that cell to lyse any target cell which expresses receptors for IgG2a. Thus, allotype-positive, Lyt-2+ T lymphocytes from either concanavalin A- or F23.1-activated cell cultures are recruited as cytotoxic effector cells which lyse targets via the Fc receptor. Concanavalin A-induced T cell blasts depleted of Lyt-2+ cells do not mediate cytotoxic effects in this system. The data presented here confirm earlier observations that monoclonal anti-T cell receptor antibodies attached to the surface of a cell can act as target structures for T cell-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935404     DOI: 10.1002/eji.1830151206

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.

Authors:  R De Jong; M Brouwer; V I Rebel; G A Van Seventer; F Miedema; R A Van Lier
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  Regulation of clonal growth by anti-T-cell receptor antibody-directed lysis.

Authors:  P De Berardinis; M Londei; S Carrel; M Feldmann
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

3.  Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells.

Authors:  W E Seaman; E Eriksson; R Dobrow; J B Imboden
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.